{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:18:19Z","timestamp":1761898699953,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"am","delay-in-days":248,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.clinre.2021.101827","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:11:02Z","timestamp":1635898262000},"page":"101827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201cDe novo\u201d cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!"],"prefix":"10.1016","volume":"46","author":[{"given":"Pauline","family":"Bourdeleau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Larrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Allaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Charlotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-120X","authenticated-orcid":false,"given":"Jean Christophe","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lebray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2021.101827_bib0001","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2021.101827_bib0002","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"T Goode","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101827_bib0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"issue":"22","key":"10.1016\/j.clinre.2021.101827_bib0004","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v7.i22.2396","article-title":"Liver transplantation for cholangiocarcinoma: current status and new insights","volume":"7","author":"Sapisoch\u00edn","year":"2015","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2021.101827_bib0005","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1034\/j.1600-6143.2003.00110.x","article-title":"De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant","volume":"3","author":"Heneghan","year":"2003","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.clinre.2021.101827_bib0006","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1111\/j.1432-2277.2011.01324.x","article-title":"Cholangiocarcinoma complicating recurrent primary sclerosing cholangitis after liver transplantation","volume":"24","author":"Khorsandi","year":"2011","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.clinre.2021.101827_bib0007","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001725","article-title":"Risk factors and outcomes of de novo cancers (excluding nonmelanoma skin cancer) after liver transplantation for primary sclerosing cholangitis","volume":"101","author":"Mouchli","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.clinre.2021.101827_bib0008","first-page":"43385","article-title":"EASL clinical practice guidelines: liver transplantation","volume":"64","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2021.101827_bib0009","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American association for the study of liver diseases and the American society of transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.clinre.2021.101827_bib0010","doi-asserted-by":"crossref","first-page":"20107","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.clinre.2021.101827_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/lt.25310","article-title":"Longterm risk of solid organ de novo malignancies after liver transplantation: a French National study on 11,226 patients","volume":"24","author":"S\u00e9r\u00e9e","year":"2018","journal-title":"Liver Transpl"},{"issue":"17","key":"10.1016\/j.clinre.2021.101827_bib0012","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clinre.2021.101827_bib0013","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2021.101827_bib0014","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1097\/00000658-200108000-00011","article-title":"Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients","volume":"234","author":"Tocchi","year":"2001","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.clinre.2021.101827_bib0015","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1111\/j.1399-3046.2009.01220.x","article-title":"De novo cholangiocarcinoma after liver transplantation in a pediatric patient","volume":"14","author":"Channabasappa","year":"2010","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.clinre.2021.101827_bib0016","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1111\/pin.12944","article-title":"De novo perihilar cholangiocarcinoma arising in the allograft liver 15 years post-transplantation for biliary atresia","volume":"70","author":"Zen","year":"2020","journal-title":"Pathol Int"},{"key":"10.1016\/j.clinre.2021.101827_bib0017","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.canlet.2017.05.001","article-title":"The microbiome and hepatobiliary-pancreatic cancers","volume":"402","author":"Mima","year":"2017","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.clinre.2021.101827_bib0018","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30852","article-title":"Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma","volume":"71","author":"Jia","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2021.101827_bib0019","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular targeted therapies: ready for \"prime time\" in biliary tract cancer","volume":"73","author":"Lamarca","year":"2020","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121002059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121002059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:32:40Z","timestamp":1761895960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740121002059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2210740121002059"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101827","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cDe novo\u201d cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101827"}}